Patient P-02499
Synthetic patientMETA-24 · Day 168 · 45–54 · M · baseline S06Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Deteriorating
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Declining
Discontinuation risk
16%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S06
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Toxicity+10
- Nutritional resilience-6
- GI instability-3
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable35 min
worsening · -6.3 vs previous 14 d
Sleep duration
Wearable6.7 h
stable · +0.1 vs previous 14 d
Energy level
Daily log5.6/10
stable · -0.1 vs previous 14 d
Steps
Wearable4,783
worsening · -529 vs previous 14 d
GI burden
Companion19.5/100
stable · +0.6 vs previous 14 d
Adherence
Companion91.4 %
stable · +1.3 vs previous 14 d
Sleep quality
Wearable49.9/100
stable · -0.5 vs previous 14 d
Glucose, CGM daily mean
CGM136 mg/dL
stable · +2.2 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards restoration · 89 from the failing basin, 9 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -2.4 next day on high-intake days · n 18
Would not help
- Nothing clearly counter-productive in the record.
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-2.4supporter · 95%
- Simple carbohydrates-1.4no signal · 46%
- Alcohol+0.9no signal · 29%
- Histamine load+0.6no signal · 17%
- Dietary fat load-0.4no signal · 15%
- Ultra-processed food-0.4no signal · 15%
- Caffeine+0.1no signal · 15%
- Insoluble fibre0no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3.2 · butyrate capacity 66/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 55 ms
- Sleep
- 6.6 h
- Steps
- 4,703
- Resting HR
- 59 bpm
Daily log: GI score 20, nutritional resilience 59, adherence 91.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02277 | 46% | S05 | AD-05 | improved | 92 |
| P-02555 | 46% | S01 | AD-05 | no change | 79 |
| P-02013 | 45% | S14 | BR-03 | no change | 94 |
| P-02282 | 44% | S01 | BR-03 | no change | 88 |
| P-02193 | 44% | S11 | CR-01 | improved | 87 |
| P-02354 | 31% | S01 | CR-01 | improved | 78 |
| P-02081 | 45% | S20 | DT-01 | no change | 88 |
| P-02565 | 44% | S09 | DT-01 | no change | 79 |
| P-02337 | 42% | S18 | DT-01 | no change | 100 |
| P-02249 | 38% | S09 | DT-01 | improved | 100 |
| P-02462 | 32% | S12 | DT-01 | improved | 65 |
| P-02518 | 31% | S17 | DT-01 | improved | 68 |